A novel approach was used to develop and validate a bioanalytical RP-HPLC method for the simultaneous estimation of Paracetamol and Cefixime in rabbit plasma using Cefaclor as internal standard. Evaluation of the content of drugs were done by employing a mixture of Phosphate buffer (p H 6.4) and Acetonitrile (80:20, v/v) as the mobile phase and measure the absorbance at 245 nm for Paracetamol and Cefixime. Retention time was established to be 3.618 min for Cefaclor, 4.608 min for Paracetamol and 5.914min for Cefixime. The results shown that the analytical technique furnished here establishes acceptable accuracy and precision, shorter and easy sample preparation, reduced the complications for equipment on satisfactory analysis time.
INTRODUCTION
Paracetamol (Figure 1 ) is chemically N-(4-hydoxyphenyl) ethanamide and it was a nonsteroidal anti-inflammatory drug having potent antipyretic, analgesic and anti-inflammatory action [1] [2] . Paracetamol was used for the pains and high temperature fevers 3 . Paracetamol acts by selectively inhibiting the prostaglandin biosynthesis. The bioavailability of the Paracetamol was 80% 4 . Cefixime ( Figure 2 ) is chemically (6R,7R)-7-((2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl)amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo(4.2.0)octo-2-ene-2-carboxylic acid and it was a third generation cephalosporin antibiotic used for the several bacterial infections [5] [6] . Cefixime acts by binding to specific penicillin binding protein leads to inhibiting bacterial cell wall synthesis and the bioavailability was 40% to 50% 7 . Cefaclor ( Figure 3 ) is chemically 3-chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate and it was a semisynthetic cephalosporin antibiotic for oral administration. Cefaclor is used to reduce the development of drugresistant bacteria.
Literature sur vey revealed that few analytical methods have been reported for estimation of Paracetamol and Cefixime individually or in combination with other drugs. The reported methods are Spectrophotometric [8] [9] [10] , HPLC [11] [12] [13] [14] , HPTLC [15] [16] and LC-MS [17] [18] . Although no method was reported for the simultaneous estimation of Paracetamol and Cefixime in combined pharmaceutical formulations.
The present study was aimed to develop a simple, sensitive, rapid, precise and accurate and validated the bionalytical method 19 for simultaneous estimation of Paracetamol and Cefixime according to ICH guidelines 20 by using high performance liquid chromatography in rabbit plasma. 
EXPERIMENTAL

Instrumentation
The analysis was performed by using a chromatographic system Water 2695 series HPLC comprised of vacuum degas, auto injector, dual gradient pump with photo diode array detector. The HPLC system was equipped with Empower 2 software.
Chromatographic conditions
Paracetamol and Cefixime was analysed in ODS C18 column (250mmx4.6mm, 5µm particle size) for the chromatographic separation. The mobile phase was composed of Phosphate buffer (p H 6.4) and Acetonitrile (80:20, v/v) and was used as diluent. Filtered through 0.45µm nylon membrane filter under vacuum filtration and pumped at a temperature of 30 0 C, at flow rate of 1ml/min with UV detection wavelength at 245nm. Injection volume was 10µl. The run time was 8min and the retention time of Paracetamol and Cefixime was found to be 4.608min and 5.914min respectvily.
Preparation of stock solutions
Primary stock solutions of Paracetamol and Cefixime were prepared individually by dissolving Series of working solutions of Paracetamol and Cefixime were prepared by the suitable dilution of the stock solutions with same diluent to achieve the concentration range of 10-100µg/ml for Paracetamol and 5-50µg/ml for Cefixime.
Procedure
The standard solutions were prepared by dilution of the stock solution with diluent to obtain a concentration range 10-100µg/ml for Paracetamol and 5-50µg/ml for Cefixime. Triplicate of 10µl injections were prepared for each concentration and chromatographed under the conditions reported above. The peak area of each concentration was plotted against the corresponding concentration for getting the calibration curve and the regression equation was computed.
Preparation of spiked plasma sample
250µl of rabbit plasma, 50µl of internal standard, 10µl of Paracetamol and 10µl of Cefixime were pipetted into 10ml centrifuge tube and to it 2ml of Acetonitrile was added. The mixture was mixed shortly, standing for 5min at room temperature, then vortex for 3 min, finally the mixture was centrifuged at 3200rpm for 10min. After the centrifugation, 10 µl of the supernantant layer was collected and injected into HPLC. 
Calibration and linearity
Calibration curves were plotted in the concentration range of 10-100µg/ml and 5-50 µg/ ml for Paracetamol and Cefixime respectively of required concentrations in the measured samples. Triplicate of 10µl injections were constructed for each working standard solution. The peak area for each concentration was measured and subsequently to draw against the each concentration to obtain the calibration curve.
Method validation Linearity
Calibration curves showed the relation between the concentrations of drugs versus peak area were established. Results manifest linear relationship in the range of 10-100µg/ml and 5-50µg/ ml for Paracetamol and Cefixime. In two drugs run from which linear regression equation was measured by following ICH guidelines shown in Figure 4 and Figure 5 .
Precision and accuracy
Results from the validation data from rabbit plasma were within the acceptable limits. Within batch precision method was measured to range from 6.21 to 8.96% for Paracetamol and 3.16 to 7.73% for Cefixime. The accuracy of the method was measured in the range of 96.33 to 106.0% for Paracetamol and 96.00 to 105.67% for Cefixime shown in Table 1 .
Recovery
The analyte recovery for the Paracetamol and Cefixime were measured to be 50.63% and 51.74% respectively. The internal standard for Cefaclor was found to 57.20% shown in Table 2 .
Stability studies Long term stability
The concentration of sample of stability ranged between 99.27 to 104.86% for Paracetamol and 93.08 to 98.71% for Cefixime of the utility value shown in Table 3 .
Freeze-thaw stability
The sample concentration of freeze-thaw stability was measured to be 97.83 to 104.83% for Paracetamol and 100.97 to 104.60% for Cefixime of utility concentraton showing the stability of the drug above three freeze-thaw cycles shown in Table 4 .
Bench top stability
The drug was developed to be stable for at least 4 hours on bench top at room temperature. The freshly spiked calibration standards against back calculated concentration was within a range of 94.02 Table 5 .
Sample stability
The concentration of sample of stability was measured range of 99.46 to 99.94% at 2-8 0 C and 98.73 to 101.38% at room temperature for Paracetamol and Cefixime, respectively shown in Table 6 .
REULTS AND DISCUSSION
Different stationary phases were tried with various columns, poor and bend peakes were observed with different columns while C18 column gave satisfactory resolution and free from tailing. Several mobile phases used like Methanol with Acetonitrile were found to separate the compounds doubtful and Potassium dihydrogen phosphate buffer with Acetonitrile lead to good separation. The present study objective was acquired using mobile phase be composed of Phosphate buffer:Acetonitrile in the ratio of 80:20, v/v with the p H adjusted to 6.4±0.2 with Orthophosphoric acid. The mobile phase composition is optimized under described conditions, free from tailing, peaks are well defined, resolved, the tailing factors were < 2 for all peaks. The retension times for Paracetamol was 4.608min and for Cefixime was 5.914min respectvily, at flow rate of 1ml/min. The optimum wavelength for detection was 245nm at where much better detector responses for the two drugs were obtained. The chromatograms of rabbit plasma blank and drugs Cefaclor, Paracetamol and Cefixime were shown in Figure 6 & 7 respectively.
